Another molecular mechanism through which PGZ works is the regulation of AKT/GSK3β activation, resulting in improved peripheral and central insulin sensitivity, increased Aβ42 degradation, and decreased Aβ accumulation in diet-induced insulin resistance rats [135]. The gene discussed is GSK3B; the disease is Insulin resistance.